Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Gyeongseon | - |
dc.contributor.author | Kang, Daewon | - |
dc.contributor.author | Cheong, Hee Jin | - |
dc.contributor.author | Choi, Sang-Eun | - |
dc.date.accessioned | 2022-08-11T02:41:10Z | - |
dc.date.available | 2022-08-11T02:41:10Z | - |
dc.date.created | 2022-08-10 | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 2076-393X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/142809 | - |
dc.description.abstract | The South Korean government has successfully improved influenza vaccination coverage for individuals aged 65 years or older as part of its National Immunization Program (NIP). Those aged 50-64 years without funded vaccination care have significantly lower vaccination rates and face a substantial risk of influenza-related complications. We use a dynamic epidemiological and economic model to investigate the cost-effectiveness of expanding the universal vaccine fund to include those aged 50-64. The epidemiological model is estimated using the susceptibility-infection-recovery model and influenza and influenza-like illness incidence rates, which were calculated by the National Health Insurance Service-National Sample Cohort from the 2008/09 to 2012/13 influenza seasons but excluding the 2009/10 season for pandemic influenza A (H1N1). The decision tree economic model is assessed from societal and healthcare sector perspectives. The proposed policy would eliminate 340,000 annual influenza cases and prevent 119 unnecessary deaths. From a societal perspective, the proposed policy would reduce costs by USD 68 million. From a healthcare perspective, the cost is USD 4318 per quality-adjusted life years. Within the study range, sensitivity analyses found consistent cost-effectiveness results. The influenza vaccine for adults aged 50-64 appears to be cost-saving or cost-effective and, thus, should be considered for the NIP. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | AGED 50-64 YEARS | - |
dc.subject | SEASONAL INFLUENZA | - |
dc.subject | WORKING ADULTS | - |
dc.subject | UNITED-STATES | - |
dc.subject | TRANSMISSION | - |
dc.subject | IMMUNIZATION | - |
dc.subject | IMPACT | - |
dc.subject | EFFICACY | - |
dc.subject | VACCINES | - |
dc.subject | MODEL | - |
dc.title | Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Sang-Eun | - |
dc.identifier.doi | 10.3390/vaccines10060932 | - |
dc.identifier.scopusid | 2-s2.0-85132153531 | - |
dc.identifier.wosid | 000817374100001 | - |
dc.identifier.bibliographicCitation | VACCINES, v.10, no.6 | - |
dc.relation.isPartOf | VACCINES | - |
dc.citation.title | VACCINES | - |
dc.citation.volume | 10 | - |
dc.citation.number | 6 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | AGED 50-64 YEARS | - |
dc.subject.keywordPlus | SEASONAL INFLUENZA | - |
dc.subject.keywordPlus | WORKING ADULTS | - |
dc.subject.keywordPlus | UNITED-STATES | - |
dc.subject.keywordPlus | TRANSMISSION | - |
dc.subject.keywordPlus | IMMUNIZATION | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | VACCINES | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordAuthor | influenza | - |
dc.subject.keywordAuthor | vaccination | - |
dc.subject.keywordAuthor | cost-effectiveness | - |
dc.subject.keywordAuthor | economic evaluation | - |
dc.subject.keywordAuthor | adults aged 50-64 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.